← Leaderboards
Ndivhu Makhado
Sefako Makgatho Health Sciences University
$873,334
Attributed
$1,746,667
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,746,667 · 1
By mechanism
R01$1,746,667 · 1
Top collaborators
- Adrie Jc Steyn5 shared
Others in their field
Other Emerging Leaders on “Fitness”
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,976,855
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Russell T Hepple · California Pacific Med Ctr Res Institute$12,760,565
- John Damon Chodera · Sloan-Kettering Inst Can Research$11,593,483
Research focus
FitnessFlexibilityExtracellularBacillusExtreme Drug Resistant TuberculosisAlabamaBioenergeticsCollaborationsCarbonCountryCause Of DeathDrug MetabolismDrug ResistanceClinical InvestigatorCohortDrug TargetingDrug ToleranceElectron TransportEnergy MetabolismExcretory FunctionExhibitsExperimental StudyDrug EffluxFrequencies
Grant awards (5)
Target and Non-target Based Resistance to Bedaquiline in South Africa$349,562
R01 · FY2024 · AI · contact PI
Target and Non-target Based Resistance to Bedaquiline in South Africa$347,754
R01 · FY2023 · AI · contact PI
Target and Non-target Based Resistance to Bedaquiline in South Africa$349,793
R01 · FY2022 · AI · contact PI
Target and Non-target Based Resistance to Bedaquiline in South Africa$349,601
R01 · FY2021 · AI · contact PI
Target and Non-target Based Resistance to Bedaquiline in South Africa$349,957
R01 · FY2020 · AI · contact PI